Grannus Therapeutics

Grannus Therapeutics

Biotechnology

Indianapolis, IN 188 followers

A pre-clinical stage biotechnology company focused on small molecule inhibitors for the treatment of serious diseases

About us

Founded in 2019, Grannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms of HSP90. Our lead program is focused on the development of a highly selective small molecule inhibitor of HSP90𝛽 for the treatment of multiple types of cancer. With this program, we have successfully engineered a molecule that selectively inhibits HSP90𝛽, potentially delivering the efficacy benefits of previous pan-inhibitors without their toxicity and dosing challenges.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Indianapolis, IN
Type
Privately Held
Founded
2019

Locations

Employees at Grannus Therapeutics

Updates

Similar pages

Browse jobs

Funding

Grannus Therapeutics 3 total rounds

Last Round

Debt financing

US$ 800.0K

See more info on crunchbase